[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100635710":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":15,"locations":21,"responsibleParty":39,"collaborators":43,"id":65,"slug":10,"hasResults":66,"nctId":67,"briefTitle":68,"officialTitle":69,"acronym":10,"eligibilityCriteria":70,"healthyVolunteers":66,"sex":71,"minAge":72,"maxAge":73,"enrollmentInfo":74,"targetDuration":10,"studyType":77,"phases":10,"briefSummary":78,"conditions":79,"keywords":10,"overallStatus":23,"whyStopped":10,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"China-Japan Friendship Hospital","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"exposed group",null,"Participants who receive integrated Traditional Chinese and Western Medicine therapy during the follow-up period.",{"label":13,"type":10,"description":14,"interventionNames":10},"non-exposed group","Participants who receive only Western medicine therapy during the follow-up period.",[16],{"name":17,"role":18,"phone":19,"phoneExt":10,"email":20},"Jiaqi Liu","CONTACT","+86 19804148523","benxiliujiaqi@163.com",[22],{"facility":5,"status":23,"city":24,"state":25,"zip":26,"country":27,"cosmosGeoPoint":28,"geoPoint":33,"contacts":34},"RECRUITING","Beijing","Beijing Municipality","100029","China",{"type":29,"coordinates":30},"Point",[31,32],116.39723,39.9075,{"lat":32,"lon":31},[35],{"name":36,"role":18,"phone":37,"phoneExt":10,"email":38},"Yuqiao Zhang","+86 13520678396","13661102043@163.com",{"type":40,"investigatorFullName":41,"investigatorTitle":42,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Qingwen Tao","Chief physician",[44,46,48,50,52,54,56,59,61,63],{"name":45,"class":6},"The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine",{"name":47,"class":6},"Guangxi Ruikang Hospital",{"name":49,"class":6},"The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine",{"name":51,"class":6},"Beijing Electric Power Hospital",{"name":53,"class":6},"Hunan University of Traditional Chinese Medicine",{"name":55,"class":6},"Affiliated Hospital of Liaoning University of Traditional Chinese Medicine",{"name":57,"class":58},"Xi'an Fifth Hospital","UNKNOWN",{"name":60,"class":6},"Affiliated Hospital of Shandong University of Traditional Chinese Medicine",{"name":62,"class":6},"Shanghai University of Traditional Chinese Medicine",{"name":64,"class":58},"Shunyi Hospital, Beijing Traditional Chinese Medicine Hospital","100635710",false,"NCT07556224","Evaluating the Efficacy and Short-Term Prognosis of Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis(AS): A Protocol for a Cohort Study","Evaluating the Efficacy and Short-Term Prognosis of Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis(AS): A Protocol for a Prospective Multicenter Cohort Study","Inclusion Criteria:\n\n* fulfill the 1984 modified New York criteria for ankylosing spondylitis or the 2009 Assessment of SpondyloArthritis International Society (ASAS) classification criteria for axial spondyloarthritis\n* age between 18 and 75 years\n* sign informed consent.\n\nExclusion Criteria:\n\n* diagnosis of other autoimmune diseases besides the disease under investigation (e.g., rheumatoid arthritis, Sjögren's syndrome, erythema nodosum, myositis, etc.)\n* pregnancy or lactation\n* comorbid severe cardiovascular or cerebrovascular diseases, hepatic or renal failure, or malignancy\n* spondyloarthritis related to enteropathic arthritis, psoriatic arthritis, or reactive arthritis\n* unable to provide data due to mental, language, or similar factors.","ALL","18 Years","75 Years",{"count":75,"type":76},790,"ESTIMATED","OBSERVATIONAL","This study is a multicenter, prospective cohort study designed to systematically evaluate the clinical efficacy of integrated Traditional Chinese and Western Medicine on short-term functional improvement in patients with ankylosing spondylitis, with the Bath Ankylosing Spondylitis Functional Index (BASFI) at 6 months of treatment as the primary outcome measure.",[80],"Ankylosing Spondylitis (AS)","2026-04-22",{"date":83,"type":84},"2026-04-29","ACTUAL",{"date":86,"type":84},"2026-01-19",{"date":88,"type":76},"2028-06-30",{"name":5,"class":6},1]